Primary Bone and Soft Tissue Tumors: Nuclear Medicine in Current Algorithms Primer Kemik ve Yumuşak Doku Tümörleri: Güncel Algoritmalarda Nükleer Tıp
Nuclear Medicine Seminars, cilt.8, sa.1, ss.82-91, 2022 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.4274/nts.galenos.2022.0009
- Dergi Adı: Nuclear Medicine Seminars
- Derginin Tarandığı İndeksler: Scopus, EMBASE
- Sayfa Sayıları: ss.82-91
- Anahtar Kelimeler: bone scintigraphy, Bone tumors, PET/CT
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
The main purpose of evaluating musculoskeletal system (MSS) tumors is diagnosis and staging, and these tumors require a multidisciplinary approach. The role of fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and bone scintigraphy in the initial evaluation of incidentally detected bone lesions on magnetic resonance (MR) imaging and CT and primary bone tumors is limited. In cases where clinical or radiographic findings are considered suspicious or additional anatomical data are required; Advanced imaging modalities such as CT, MR and nuclear medicine examinations play a complementary role in the diagnosis and treatment of primary MSS tumors. The advantage of nuclear medicine examinations over radiography or MRI is the capacity to scan the whole body; it can be used for standard staging, restaging, and evaluation of therapeutic response. In addition, PET/MR appears to have strong potential in soft tissue sarcoma staging and bone marrow evaluation.